NASDAQ: SEPNSepterna Inc Stock Ownership - Who owns Septerna?
Insider buying vs selling
Have Septerna Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Elizabeth Bhatt | COO;Pres | 2026-07-15 | 4,000 | $6.81 | $27.24kBuy |
| Elizabeth Bhatt | COO;Pres | 2026-07-15 | 4,000 | $33.99 | $135.97kSell |
| Daniel D. Long | SVP Drug Discovery | 2026-07-01 | 1,233 | $34.81 | $42.93kSell |
| Daniel D. Long | SVP Drug Discovery | 2026-07-01 | 2,100 | $34.10 | $71.60kSell |
| Daniel D. Long | SVP Drug Discovery | 2026-07-01 | 3,333 | $2.76 | $9.20kBuy |
| Samira Shaikhly | Chief People Officer | 2026-06-29 | 2,178 | $35.18 | $76.62kSell |
| Samira Shaikhly | Chief People Officer | 2026-06-29 | 2,178 | $6.81 | $14.83kBuy |
| Daniel D. Long | SVP Drug Discovery | 2026-06-22 | 10,529 | $2.76 | $29.06kBuy |
| Daniel D. Long | SVP Drug Discovery | 2026-06-22 | 4,471 | $11.70 | $52.31kBuy |
| Daniel D. Long | SVP Drug Discovery | 2026-06-22 | 8,000 | $35.10 | $280.80kSell |
SEPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SEPN insiders and whales buy or sell their stock.
SEPN Shareholders
What type of owners hold Septerna Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Third Rock Ventures VI LP | 23.13% | 10,427,250 | $350.46M | Insider |
| Third Rock Ventures V LP | 20.78% | 9,368,047 | $314.86M | Insider |
| Ra Capital Management LP | 15.52% | 6,995,858 | $235.13M | Institution |
| Trv GP V LLC | 13.79% | 6,215,591 | $208.91M | Institution |
| Driehaus Capital Management LLC | 9.75% | 4,395,572 | $147.74M | Institution |
| Trv GP VI LLC | 9.34% | 4,211,659 | $141.55M | Institution |
| Samsara Biocapital LLC | 6.99% | 3,149,128 | $105.84M | Institution |
| Goldman Sachs Group Inc 1 | 6.45% | 2,906,427 | $97.69M | Institution |
| Siren LLC | 4.44% | 2,000,000 | $67.22M | Institution |
| Blackrock Inc | 4.04% | 1,822,174 | $61.24M | Institution |
SEPN vs Biotech Stocks
Septerna Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.